A randomized phase II study of sequential docetaxel and doxorubicin/cyclophosphamide in patients with metastatic breast cancer
2002 · Annals of Oncology · 39 citations
https://doi.org/10.1093/annonc/mdf222
Mayo Clinic(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
15
Papers
738
Citations
9
h-index
9
i10-index
J C Michalak is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Cancer Treatment and Pharmacology & Chemotherapy-related skin toxicity & Lymphoma Diagnosis and Treatment. The author has an h-index of 9, co-authored 13 publications.
Click to start Chat